RNA therapies hold tremendous promise for treating genetic eye diseases. However, their development is limited by the lack of ...
CRISPR-Cas13d is increasingly used for RNA knockdowns, but off-target cleavage of near-cognate RNAs hinders its broader ...
Eighty healthcare workers from public hospitals in Lilongwe have undergone training in early lung cancer detection to increase chances of successful treatment and survival. Oncologist Richard ...
The New Mexico Cancer Center Foundation offered free screenings for lung cancer. The center says the calendar for 2026 has filled. If you need or feel like you need a lung cancer screening, you should ...
Scientists have developed a liquid biopsy platform that detects multiple types of cancer with a single test by analyzing complex patterns in blood samples, using a strategy similar to the human sense ...
SAN ANTONIO--(BUSINESS WIRE)--$BIAF #BIAF--bioAffinity Technologies, Inc. (Nasdaq: BIAF; BIAFW), a biotechnology company focused on noninvasive diagnostics and early ...
SAN ANTONIO, July 27, 2026--(BUSINESS WIRE)--bioAffinity Technologies, Inc. (Nasdaq: BIAF; BIAFW), a biotechnology company focused on noninvasive diagnostics and early cancer detection, today ...
bioAffinity Technologies, Inc.(Nasdaq: BIAF; BIAFW), a biotechnology company focused on noninvasive diagnostics and early cancer detection, today announced the publication of a comprehensive clinical ...
Javascript is required for you to be able to read premium content. Please enable it in your browser settings.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results